Co-creation is not a buzzword. How Pharma teams can make it work (with a little help from AI)
How do you future-proof your engagement strategy without falling back on the same old tactics? One insight stood out: co-creation is no longer optional.
Beyond Pharma: What Global Media Trends Reveal About the Future of Healthcare Communication
Discover what the latest global media trends reveal about the future of healthcare communication. From the shift to video content to the rise of new digital platforms, learn how these insights can help pharma engage more effectively with patients and healthcare professionals.
Enhancing customer experience, from strategy to tactics
New tech combining forensic linguistics and machine learning yields surprising insights into what does and doesn’t work in HCP communication
Summaries are key to pharma’s effective communication with HCPs
New tech combining forensic linguistics and machine learning yields surprising insights into what does and doesn’t work in HCP communication
Case Study: Turning EFSA’s complex scientific outputs into Plain Language Summaries to engage stakeholders
Introduction The European Food Safety Authority (EFSA), an agency of the European Union, delivers independent and transparent scientific advice to stakeholders within the food chain ‘to protect European consumers from food related risks.’ A key element of EFSA’s mission is to promote coherence in EU risk communication. All EFSA scientific outputs are published open access …
‘Wow’ versus ‘How’: Rethinking Content Creation in Pharma and Healthcare
The quest for ‘wow’ in content creation often overshadows the need for meaningful substance, particularly in pharma and healthcare. Sabine Louët, Founder of SciencePOD, highlights the dilemma facing marketers: achieving a ‘wow’ factor that attracts attention while ensuring the content remains credible, relevant, and clear. The article delves into how healthcare professionals (HCPs) prioritise content that is not only attention-grabbing but also trustworthy and scientifically robust.
Omnichannel, data, and the HCP portal experience
Interview with Martin Møller, Global Director Omnichannel & CX Excellence, Novo Nordisk Martin Møller is the Global Director of Omnichannel & CX Excellence at Novo Nordisk. He is scheduled to speak at the Pharma Omnichannel HCP Engagement Conference, 23-24 May 2024, in Lisbon, at a session titled ‘Omnichannel Engagement Track: The HCP Portal as the …
Omnichannel, data, and the HCP portal experience Read More »
Emerging technologies in the journey to HCP engagement
In an exclusive interview with SciencePOD, Sarah Christensen of Novartis unveils the future of HCP engagement through data-driven, personalised communication and cutting-edge AI technologies, ahead of her panel at Reuters Events: Pharma 2024.
Overcoming siloed thinking on the journey to omnichannel engagement
Interview with Laëtitia Bouérat Duvold, Senior Director & Head of Global Medical Affairs Excellence, Lundbeck Laëtitia Bouérat Duvold, Senior Director & Head of Global Medical Affairs Excellence at Lundbeck, is scheduled to speak at the NEXT Pharma Summit in Dubrovnik, 14-15 May 2024 in a session entitled “Medical engagement and its place in Omnichannel. How …
Overcoming siloed thinking on the journey to omnichannel engagement Read More »
Innovate customer facing interactions
Join us for an exclusive interview with Donatello Crocetta, SVP at UCB, as he shares insights into innovative customer-facing roles and digital advancements in healthcare ahead of his panel at Reuters Events Pharma 2024.